[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with Iron deficiency anemia.\nHF Categories:\n\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nICD Codes:\n\nHFrEF = I50.2 and I50.4\nHFpEF = I50.3\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with Iron deficiency anemia.\nHF Categories:\n\nHeart failure with reduced ejection fraction\nHeart failure with preserved ejection fraction\n\nICD Codes:\n\nHFrEF = I50.2 and I50.4\nHFpEF = I50.3\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nHeart failure with preserved ejection fraction\nN = 520,8851\nHeart failure with reduced ejection fraction\nN = 425,4051\np-value2\n\n\n\n\nAge, y\n73 (13)\n70 (14)\n&lt;0.001\n\n\nSex\n\n\n\n\n&lt;0.001\n\n\n    Female\n330,210 (63%)\n186,740 (44%)\n\n\n\n\n    Male\n190,655 (37%)\n238,655 (56%)\n\n\n\n\nRace\n\n\n\n\n&lt;0.001\n\n\n    White\n354,990 (70%)\n258,350 (62%)\n\n\n\n\n    Asian or Pacific Islander\n10,010 (2.0%)\n8,290 (2.0%)\n\n\n\n\n    Black\n94,210 (18%)\n100,970 (24%)\n\n\n\n\n    Hispanic\n37,305 (7.3%)\n35,570 (8.5%)\n\n\n\n\n    Native American\n3,025 (0.6%)\n2,855 (0.7%)\n\n\n\n\n    Other\n10,755 (2.1%)\n10,390 (2.5%)\n\n\n\n\nElixhauser comorbidity index\n7.94 (1.98)\n7.91 (2.03)\n0.001\n\n\nResidential income\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n160,825 (31%)\n146,185 (35%)\n\n\n\n\n    $52,000 - $65,999\n137,745 (27%)\n111,610 (27%)\n\n\n\n\n    $66,000 - $87,999\n121,180 (24%)\n92,425 (22%)\n\n\n\n\n    $88,000 or more\n94,155 (18%)\n67,050 (16%)\n\n\n\n\nHospital bed size\n\n\n\n\n&lt;0.001\n\n\n    Large\n254,220 (49%)\n225,295 (53%)\n\n\n\n\n    Medium\n150,660 (29%)\n115,580 (27%)\n\n\n\n\n    Small\n116,005 (22%)\n84,530 (20%)\n\n\n\n\nHospital location/teaching status\n\n\n\n\n&lt;0.001\n\n\n    Rural\n47,500 (9.1%)\n33,265 (7.8%)\n\n\n\n\n    Urban, non-teaching\n92,605 (18%)\n69,685 (16%)\n\n\n\n\n    Urban, teaching\n380,780 (73%)\n322,455 (76%)\n\n\n\n\nExpected primary payer\n\n\n\n\n&lt;0.001\n\n\n    Private\n58,710 (11%)\n61,025 (14%)\n\n\n\n\n    Medicaid\n42,755 (8.2%)\n54,060 (13%)\n\n\n\n\n    Medicare\n411,755 (79%)\n301,790 (71%)\n\n\n\n\n    Other\n7,275 (1.4%)\n8,100 (1.9%)\n\n\n\n\nHospital region\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n148,350 (28%)\n113,875 (27%)\n\n\n\n\n    Northeast\n102,585 (20%)\n72,805 (17%)\n\n\n\n\n    South\n190,475 (37%)\n164,665 (39%)\n\n\n\n\n    West\n79,475 (15%)\n74,060 (17%)\n\n\n\n\nHypertension\n479,320 (92%)\n382,430 (90%)\n&lt;0.001\n\n\nHyperlipidemia\n299,290 (57%)\n240,825 (57%)\n&lt;0.001\n\n\nPeripheral vascular disease\n67,155 (13%)\n102,640 (24%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n234,725 (45%)\n159,285 (37%)\n&lt;0.001\n\n\nCoronary artery disease\n220,005 (42%)\n240,850 (57%)\n&lt;0.001\n\n\nDementia\n53,610 (10%)\n35,555 (8.4%)\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n255,665 (49%)\n210,930 (50%)\n0.034\n\n\nValvular heart disease\n140,640 (27%)\n124,005 (29%)\n&lt;0.001\n\n\nAtrial fibrillation\n198,540 (38%)\n160,570 (38%)\n0.11\n\n\nBMI\n\n\n\n\n&lt;0.001\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n25,660 (15%)\n19,450 (18%)\n\n\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n26,335 (16%)\n16,930 (16%)\n\n\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n78,885 (47%)\n36,505 (34%)\n\n\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n10,070 (6.0%)\n9,900 (9.1%)\n\n\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n11,610 (6.9%)\n9,965 (9.2%)\n\n\n\n\n    Underweight (BMI ≤19.9kg/m²)\n14,625 (8.7%)\n15,550 (14%)\n\n\n\n\nPresence of pacemaker\n44,780 (8.6%)\n82,540 (19%)\n&lt;0.001\n\n\nprevious MI\n56,800 (11%)\n83,995 (20%)\n&lt;0.001\n\n\nPior cardiac surgery\n70,565 (14%)\n77,805 (18%)\n&lt;0.001\n\n\nDepression\n94,465 (18%)\n64,350 (15%)\n&lt;0.001\n\n\nCancer\n31,470 (6.0%)\n25,145 (5.9%)\n0.2\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Outcomes in HFrEF vs HFpEF in Patients with Iron Deficiency Anemia",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nHeart failure with preserved ejection fraction\nN = 520,8851\nHeart failure with reduced ejection fraction\nN = 425,4051\np-value2\n\n\n\n\nDied during hospitalization\n15,395 (3.0%)\n16,390 (3.9%)\n&lt;0.001\n\n\nLength of stay (days)\n6.9 (7.1)\n7.5 (8.6)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n74,877 (98,061)\n92,846 (156,520)\n&lt;0.001\n\n\n\n1 n (%); Mean (SD)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test\n\n\n\n\n\n\n\n\n\nMultivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n1.48\n1.34, 1.65\n&lt;0.001\n\n\nAge, y\n1.03\n1.02, 1.03\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.23\n1.10, 1.37\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.97\n0.65, 1.45\n0.9\n\n\n    Black\n0.92\n0.80, 1.06\n0.3\n\n\n    Hispanic\n0.89\n0.72, 1.11\n0.3\n\n\n    Native American\n0.80\n0.35, 1.81\n0.6\n\n\n    Other\n1.15\n0.83, 1.60\n0.4\n\n\nElixhauser comorbidity index\n1.31\n1.26, 1.35\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.91\n0.80, 1.04\n0.2\n\n\n    $66,000 - $87,999\n0.89\n0.78, 1.03\n0.12\n\n\n    $88,000 or more\n0.92\n0.78, 1.08\n0.3\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.84\n0.67, 1.05\n0.13\n\n\n    Medicare\n0.86\n0.73, 1.01\n0.074\n\n\n    Other\n1.40\n0.98, 1.99\n0.068\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.09\n0.92, 1.28\n0.3\n\n\n    South\n0.98\n0.86, 1.11\n0.7\n\n\n    West\n0.88\n0.74, 1.04\n0.14\n\n\nHospital bed size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.96\n0.85, 1.09\n0.6\n\n\n    Small\n0.88\n0.77, 1.01\n0.075\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.90\n0.73, 1.11\n0.3\n\n\n    Urban, teaching\n0.91\n0.75, 1.09\n0.3\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.52\n0.44, 0.61\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.66, 0.81\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.68, 0.91\n0.002\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.75, 0.95\n0.005\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.71\n0.64, 0.80\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.68, 0.88\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.10\n0.93, 1.30\n0.3\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n0.91, 1.32\n0.4\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.08\n1.83, 2.36\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.85, 1.06\n0.4\n\n\nBMI\n\n\n\n\n\n\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n—\n—\n\n\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n0.86\n0.69, 1.06\n0.14\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n1.31\n1.11, 1.54\n0.002\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n1.63\n1.32, 2.02\n&lt;0.001\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n1.28\n1.03, 1.59\n0.026\n\n\n    Underweight (BMI ≤19.9kg/m²)\n2.13\n1.78, 2.56\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.68, 0.96\n0.014\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.04\n0.88, 1.23\n0.7\n\n\nDepression\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.69\n0.60, 0.79\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.93\n0.78, 1.10\n0.4\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\n\nMultivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n0.61\n0.46, 0.75\n&lt;0.001\n\n\nAge, y\n-0.01\n-0.02, -0.01\n0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.41\n0.26, 0.56\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.49\n-0.33, 1.3\n0.2\n\n\n    Black\n-0.04\n-0.23, 0.16\n0.7\n\n\n    Hispanic\n-0.10\n-0.38, 0.18\n0.5\n\n\n    Native American\n-0.03\n-0.78, 0.72\n&gt;0.9\n\n\n    Other\n0.31\n-0.32, 0.93\n0.3\n\n\nElixhauser comorbidity index\n0.60\n0.55, 0.66\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.18\n-0.36, 0.00\n0.045\n\n\n    $66,000 - $87,999\n-0.07\n-0.28, 0.13\n0.5\n\n\n    $88,000 or more\n0.17\n-0.09, 0.42\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.09\n-0.22, 0.40\n0.6\n\n\n    Medicare\n-0.22\n-0.45, 0.01\n0.061\n\n\n    Other\n0.13\n-0.45, 0.71\n0.7\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.1\n0.78, 1.4\n&lt;0.001\n\n\n    South\n0.49\n0.28, 0.70\n&lt;0.001\n\n\n    West\n-0.43\n-0.71, -0.15\n0.003\n\n\nHospital bed size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.92\n-1.1, -0.72\n&lt;0.001\n\n\n    Small\n-1.3\n-1.6, -1.1\n&lt;0.001\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.2\n0.87, 1.4\n&lt;0.001\n\n\n    Urban, teaching\n1.9\n1.6, 2.1\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.1\n-1.4, -0.80\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.71\n-0.85, -0.56\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.13\n-0.35, 0.09\n0.2\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.11\n-0.25, 0.04\n0.2\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.78\n-0.93, -0.63\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.34\n-0.51, -0.17\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.36\n0.09, 0.62\n0.008\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.37\n0.06, 0.68\n0.021\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.1\n1.9, 2.2\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.03\n-0.12, 0.18\n0.7\n\n\nBMI\n\n\n\n\n\n\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n—\n—\n\n\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n-0.25\n-0.45, -0.04\n0.019\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n0.59\n0.39, 0.80\n&lt;0.001\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n1.1\n0.83, 1.4\n&lt;0.001\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n0.75\n0.45, 1.1\n&lt;0.001\n\n\n    Underweight (BMI ≤19.9kg/m²)\n1.4\n1.1, 1.7\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.81\n-1.0, -0.60\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.44\n-0.63, -0.26\n&lt;0.001\n\n\nDepression\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.22\n-0.41, -0.02\n0.030\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.68\n-0.85, -0.51\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nHeart failure categories\n\n\n\n\n\n\n\n\n    Heart failure with preserved ejection fraction\n—\n—\n\n\n\n\n    Heart failure with reduced ejection fraction\n13,511\n10,983, 16,040\n&lt;0.001\n\n\nAge, y\n-588\n-716, -460\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n5,914\n3,749, 8,079\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n22,346\n6,595, 38,096\n0.005\n\n\n    Black\n-3,355\n-6,303, -407\n0.026\n\n\n    Hispanic\n15,082\n9,719, 20,445\n&lt;0.001\n\n\n    Native American\n-14,094\n-22,843, -5,345\n0.002\n\n\n    Other\n22,929\n6,059, 39,800\n0.008\n\n\nElixhauser comorbidity index\n8,007\n6,902, 9,113\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-1,315\n-4,001, 1,370\n0.3\n\n\n    $66,000 - $87,999\n-689\n-3,878, 2,500\n0.7\n\n\n    $88,000 or more\n6,835\n2,311, 11,359\n0.003\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-8,671\n-13,964, -3,378\n0.001\n\n\n    Medicare\n-4,724\n-8,911, -538\n0.027\n\n\n    Other\n2,078\n-8,491, 12,646\n0.7\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n23,286\n17,074, 29,498\n&lt;0.001\n\n\n    South\n14,333\n10,816, 17,851\n&lt;0.001\n\n\n    West\n39,533\n33,045, 46,020\n&lt;0.001\n\n\nHospital bed size\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-13,315\n-17,295, -9,335\n&lt;0.001\n\n\n    Small\n-21,077\n-24,929, -17,224\n&lt;0.001\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n25,954\n22,078, 29,829\n&lt;0.001\n\n\n    Urban, teaching\n35,931\n32,617, 39,246\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-19,722\n-24,525, -14,919\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2,419\n-4,568, -271\n0.027\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1,353\n-4,821, 2,115\n0.4\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n8,212\n5,909, 10,515\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-9,778\n-12,089, -7,468\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3,604\n581, 6,628\n0.019\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-4,850\n-8,073, -1,628\n0.003\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3,400\n-801, 7,601\n0.11\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n22,367\n20,144, 24,590\n&lt;0.001\n\n\nAtrial fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n95\n-2,314, 2,503\n&gt;0.9\n\n\nBMI\n\n\n\n\n\n\n\n\n    Class I obesity (BMI 30.0-34.9kg/m²)\n—\n—\n\n\n\n\n    Class II obesity (BMI 35.0-39.9kg/m²)\n-5,003\n-8,351, -1,655\n0.003\n\n\n    Class III obesity (BMI ≥40.0kg/m²)\n-535\n-3,655, 2,584\n0.7\n\n\n    Normal weight (BMI 20.0-24.9kg/m²)\n8,121\n3,330, 12,912\n&lt;0.001\n\n\n    Overweight (BMI 25.0-29.9kg/m²)\n8,168\n3,356, 12,981\n&lt;0.001\n\n\n    Underweight (BMI ≤19.9kg/m²)\n11,351\n6,550, 16,152\n&lt;0.001\n\n\nPresence of pacemaker\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-12,987\n-16,800, -9,173\n&lt;0.001\n\n\nprevious MI\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,737\n-13,529, -7,946\n&lt;0.001\n\n\nDepression\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,718\n-13,266, -8,170\n&lt;0.001\n\n\nPior cardiac surgery\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-16,510\n-19,371, -13,650\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]